

* Returns not adjusted for payouts
Company Profile
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
Mr. Rizwan Sheikh | CEO |
Mr. Nadeem Amjad | Chairman |
Mr. Muhammad Riaz | Company Secretary |
Aslam Malik & Co. Chartered Accountants
June
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Apr 28, 2022 | Transmission of Quarterly Report for the Period Ended March 31, 2022 | View PDF |
Apr 20, 2022 | Financial Results for the 3rd Quarter ended March 31, 2022 | View PDF |
Feb 28, 2022 | Transmission of 2nd Quarter Report for the Period ended December 31, 2021 | View PDF |
Feb 22, 2022 | Financial Results for the 2nd Quarter ended December 31, 2021 | View PDF |
Oct 29, 2021 | Financial Results for the first quarter ended September 30, 2021 | View PDF |
Oct 7, 2021 | Transmission of Annual Report for the year ended June 30, 2021 | View PDF |
Sep 30, 2021 | Financial Results for the year ended June 30, 2021 | View PDF |
Date | Title | Document |
---|---|---|
Apr 12, 2022 | Board Meeting | View |
Feb 11, 2022 | Board Meeting | View |
Dec 29, 2021 | Resolutions Passed in Annual General Meeting | View PDF |
Oct 22, 2021 | Board Meeting | View |
Oct 7, 2021 | Notice of Annual General Meeting | View PDF |
Sep 23, 2021 | Board Meeting | View |
Sep 13, 2021 | Decisions of Baord Meeting | View PDF |
Aug 31, 2021 | Board Meeting | View |
Aug 13, 2021 | Decisions of the Board Meeting | View PDF |
Aug 6, 2021 | Board Meeting | View |
Date | Title | Document |
---|---|---|
Feb 22, 2022 | Material Information | View PDF |
Feb 18, 2022 | Material Information | View PDF |
Dec 31, 2021 | Material Information | View |
Nov 25, 2021 | Credit of Final Cash Dividend | View |
Nov 22, 2021 | Material Information | View |
Nov 18, 2021 | Credit of Bonus Share Certificates | View PDF |
Nov 1, 2021 | Transmission of Quarterly Report for the period September 30, 2021 | View PDF |
Sep 16, 2021 | Material Information | View PDF |
Aug 6, 2021 | Change of Director | View |
Jul 27, 2021 | Change of Director | View |
Financials
All numbers in thousands (000's) except EPS
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Sales | 5,795,404 | 3,527,625 | 2,607,028 | 2,003,334 |
Profit after Taxation | 351,768 | 143,416 | 27,804 | 116,866 |
EPS | 4.64 | 31.87 | 6.18 | 25.97 |
Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | |
---|---|---|---|---|
Sales | 2,748,139 | 2,850,279 | 1,990,953 | 1,779,989 |
Profit after Taxation | 207,449 | 261,698 | 81,357 | 99,332 |
EPS | 0.92 | 1.11 | 0.41 | 0.74 |

Ratios
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Gross Profit Margin (%) | 13.47 | 12.39 | 12.69 | 13.12 |
Net Profit Margin (%) | 6.07 | 4.07 | 1.07 | 5.83 |
EPS Growth (%) | (85.44) | 415.70 | (76.20) | 37.70 |
PEG | (0.09) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
September 30, 2021 9:32 PM | 30/06/2021(YR) | 15% (D) - 10% (B) | 21/10/2021 - 28/10/2021 |